ArticleItalian journal of pediatrics2025
A visualized nomogram to predict intravenous immunoglobulin resistance in Kawasaki disease: a study based on the population in Southern China.
Article in Italian journal of pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Quality and performance of machine learning versus logistic regression for predicting IVIG resistance in Kawasaki disease: a PROBAST+AI systematic comparison.BMC medical research methodology · 2026Pooled it
- Machine learning prediction models for intravenous immunoglobulin resistance in Kawasaki disease: a meta-analysis.BMC medical informatics and decision making · 2026Pooled it
- Value of the neutrophil percentage-to-albumin ratio in predicting intravenous Immunoglobulin resistance in Kawasaki disease: a retrospective cohort study.Italian journal of pediatrics · 2025Article
- IL-10 and IL-2R as combined predictors of intravenous immunoglobulin resistance in Kawasaki disease: a retrospective cohort study.Frontiers in immunology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundA significant proportion of Kawasaki disease (KD) patients suffer from intravenous immunoglobulin (IVIG) resistance after initial IVIG treatment, which results in persistent coronary artery injury. This study aimed to analyze the risk factors including coagulation indicators and develop a visualized nomogram model to early predict KD patients who would be at high risk of IVIG-resistant.
methodsConsecutive KD patients receiving standard dose of IVIG in Xiamen Women and Children's Hospital between April 2014 and June 2024 were included in the study. Baseline variables were analyzed using univariate logistic regression and multivariable logistic regression to identify the predictors of IVIG-resistance and derive a nomogram model for the assessment of IVIG-resistance in KD patients. The performance of the nomogram was evaluated with the area under curve (AUC) of receiver operating characteristic, calibration curve, and decision curve analysis.
resultsA total of 541 KD patients were finally enrolled in the present study, and 7.6% of KD patients suffered from IVIG-resistant. The predictive value of coagulation indicators for IVIG-resistance may be limited except for activated partial thromboplastin time (APTT). Other independent predictors include red blood cell count, globulin, Alanine aminotransferase, and weight. The training and testing sets of nomogram scored an AUC of 0.781 (95% CI, 0.688-0.874) and 0.749 (95% CI, 0.597-0.902). The nomogram was calibrated well, and the decision curve analysis showed that the nomogram would generate more net benefit when the threshold probabilities ranged from 10 to 70%.
conclusionA visualized nomogram model was constructed to accurately predict the risk of IVIG-resistance for KD patients, and APTT may be a potential predictor of IVIG-resistant.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.